Association study of interferon gamma (IFN-γ) +874T/A gene polymorphism in patients with paranoid schizophrenia.
Schizophrenia is a multifactorial disease with changes affecting the immune system. Dysregulation of the cytokine network in schizophrenia has been well documented. Such changes may occur due to disturbances in cytokine levels that are linked to polymorphisms of cytokine genes. However, research in the role of cytokine gene polymorphisms in schizophrenia has been surprisingly scanty. The aim of this study was to identify, in a case control study, whether polymorphism of IFN-γ gene is a risk factor for the development of paranoid schizophrenia. To the best of our knowledge, this is the first study that examines the association between the IFN-γ gene polymorphism and psychopathological symptoms in patients with paranoid schizophrenia. Polymorphism of IFN-γ (+874T/A, rs 62559044) in schizophrenic patients (n=179), as well as healthy individuals (n=196), both Polish residents, was genotyped using AS-PCR method. Of note, when analyzing the results, we took into consideration the gender of studied individuals. Surprisingly, a single-nucleotide polymorphism in the first intron of the IFN-γ gene was found to be associated with paranoid schizophrenia in males, but not in females. The presence of allele A at position +874 in the IFN-γ gene correlates with 1.66-fold higher risk of paranoid schizophrenia development in males. Differences in the genotypes may have an important role in determining the level of I gene transcription. Because other polymorphisms have been demonstrated to influence IFN-γ transcription, further analysis is necessary to clarify the role of this gene in the pathogenesis of paranoid schizophrenia.
Paul-Samojedny
Monika
M
Department of Medical Genetics, Medical University of Silesia, 30, Ostrogorska Street, 41-200, Sosnowiec, Poland. mpaul@sum.edu.pl
Owczarek
Aleksander
A
Suchanek
Renata
R
Kowalczyk
Malgorzata
M
Fila-Danilow
Anna
A
Borkowska
Paulina
P
Kucia
Krzysztof
K
Kowalski
Jan
J
D000328:Adult; D000483:Alleles; D016022:Case-Control Studies; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D007371:Interferon-gamma / Q000235:genetics*; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011044:Poland; D020641:Polymorphism, Single Nucleotide; D012563:Schizophrenia, Paranoid / Q000235:genetics*; D055815:Young Adult
D007371:Interferon-gamma
Curr Pharm Des. 2005;11(8):1017-30
15777251
Hum Immunol. 2000 Sep;61(9):863-6
11053629
Clin Neurosci Res. 2006 Aug;6(1-2):52-68
18079991
Cytokine Growth Factor Rev. 2009 Feb;20(1):43-59
19038572
Psychiatry Res. 1997 Feb 7;66(2-3):145-52
9075278
J Korean Med Sci. 2009 Dec;24(6):1083-8
19949664
Biol Psychiatry. 1994 Apr 1;35(7):464-73
7517191
Ann N Y Acad Sci. 1998 Sep 29;856:22-32
9917861
Psychoneuroendocrinology. 2003 Apr;28 Suppl 2:17-54
12650680
Acta Psychiatr Scand Suppl. 2000;401:3-38
10887978
Arch Neurol. 2008 Mar;65(3):349-57
18332247
Am J Psychiatry. 1996 Sep;153(9):1178-84
8780422
Prog Neuropsychopharmacol Biol Psychiatry. 2003 Sep;27(6):1007-12
14499318
Mol Psychiatry. 1999 Jul;4(4):302-6
10483041
J Mol Neurosci. 2010 Sep;42(1):112-9
20393813
J Neurosci. 2002 Jun 1;22(11):4530-9
12040060
Psychoneuroendocrinology. 2009 Apr;34(3):382-8
18990498
Curr Pharm Des. 2005;11(8):973-84
15777248
Expert Rev Clin Immunol. 2005 May;1(1):103-12
20477658
Psychoneuroendocrinology. 2003 Apr;28 Suppl 2:83-96
12650683
Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7016-20
1908086
Am J Psychiatry. 1985 Oct;142(10):1184-6
2412455
Mol Biol Med. 1990 Aug;7(4):323-31
2122173
Clin Psychol Rev. 1998 Nov;18(7):795-819
9827322
Hum Mol Genet. 2003 Oct 15;12 Spec No 2:R125-33
12952866
Schizophr Bull. 1987;13(2):261-76
3616518
Int J Dev Neurosci. 1997 Oct;15(6):711-6
9402221
Mol Psychiatry. 2000 Nov;5(6):594-603
11126390
Immunol Lett. 1988 Mar;17(3):267-71
2453456
Am J Psychiatry. 2000 May;157(5):683-94
10784457
Schizophr Res. 2008 Sep;104(1-3):237-45
18573639
J Med Genet. 2005 Mar;42(3):193-204
15744031
Schizophr Res. 2001 Jul 1;50(3):169-75
11439237